4
Total investments
1
Early stage
0
Mid stage
0
Late stage
15y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Principal Investigator, Translational Research Program
Sep 2011
The Alliance for Clinical Trials in Oncology is a national clinical trials network sponsored by the National Cancer Institute (NCI) that consists of nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across the United States and Canada. The Alliance is dedicated to developing and conducting clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as researching methods to alleviate side effects of cancer and cancer treatments.
The Alliance is a member of the NCI National Clinical Trials Network (NCTN) and also serves as a research base for the NCI Community Research Oncology Program (NCORP).
The Alliance seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer. Our mission is three-fold:
To conduct high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network;
To further our understanding of the biological basis of the cancer process and its treatment, from discovery, to validation, to clinical practice; and
To provide a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings.
Experience · 6 entries
All (6)
Investments (4)
Board (3)
2021
Board Member
Jun 2021
The Reagan-Udall Foundation is an independent 501(c)(3) not-for-profit organization created by Congress to advance the mission of the FDA by advancing regulatory science and research. With the ultimate goal of improving public health, the Foundation provides a unique opportunity to bring all parties to the table (FDA, Patient Groups, Academia, other Government entities, and Industry) to work together in a transparent way to create exciting new regulatory science.
2018
A
American College of Genetics and Genomics (ACMG) Foundation
Board Member
Sep 2018
Board Member
Sep 2018
Founded in 1991, the American College of Medical Genetics and Genomics (ACMG) is the only nationally recognized medical society dedicated to improving health through the clinical practice of medical genetics and genomics and the only medical specialty society in the US that represents the full spectrum of medical genetics disciplines in a single organization. ACMG is the largest membership organization specifically for medical geneticists, providing education, resources and a voice for more than 2,400 clinical and laboratory geneticists, genetic counselors and other healthcare professionals, nearly 80% of whom are board certified in the medical genetics specialties. Four overarching strategies guide ACMG's work: 1) to reinforce and expand ACMG’s position as the leader and prominent authority in the field of medical genetics and genomics, including clinical research, while educating the medical community on the significant role that genetics and genomics will continue to play in understanding, preventing, treating and curing disease; 2) to secure and expand the professional workforce for medical genetics and genomics; 3) to advocate for the specialty; and 4) to provide best-in-class education to members and nonmembers. Genetics in Medicine, published monthly, is the official ACMG peer-reviewed journal. ACMG’s website (www.acmg.net) offers resources including policy statements, practice guidelines, educational programs and a ‘Find a Genetic Service’ tool. The educational and public health programs of ACMG are dependent upon charitable gifts from corporations, foundations and individuals through the ACMG Foundation for Genetic and Genomic Medicine.
Not a member? Join ACMG today at www.acmg.net/join.
Already a member? ACMG members are invited to join ACMG’s exclusive members-only group on LinkedIn at https://www.linkedin.com/groups/2409492/.
2011
Principal Investigator, Translational Research Program
Sep 2011
The Alliance for Clinical Trials in Oncology is a national clinical trials network sponsored by the National Cancer Institute (NCI) that consists of nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across the United States and Canada. The Alliance is dedicated to developing and conducting clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as researching methods to alleviate side effects of cancer and cancer treatments.
The Alliance is a member of the NCI National Clinical Trials Network (NCTN) and also serves as a research base for the NCI Community Research Oncology Program (NCORP).
The Alliance seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer. Our mission is three-fold:
To conduct high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network;
To further our understanding of the biological basis of the cancer process and its treatment, from discovery, to validation, to clinical practice; and
To provide a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings.
2010
Associate Professor of Medicine and Urology
Jul 2010
UC San Francisco is driven by the idea that when the best research, the best education and the best patient care converge, great breakthroughs are achieved. We pursue this integrated excellence with singular focus, fueled by collaboration among our top-ranked professional and graduate schools, medical center, research programs and support teams.
Show all 6 entries ↓
Investment activity
2011–2021 · 4 investments
Recent (last 2 years)Earlier
Similar investors
Medical investors in United States
Investor lists
Lists that match Dr. Phillip's portfolio
- Angel investors in the US6,019 investors
- Medical investors in United States2,829 investors
- Startup investors in United States6,245 investors






